Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Jazz Pharmaceuticals, Inc. (JAZZ) has a market cap of $12.38B with year-over-year revenue growth of +6.1%. Net margin stands at 13.8%. The stock trades at a P/E ratio of 22.1.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, JAZZ posted revenue growth of +6.1% and trades at a P/E of 22.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.